MAIA Biotechnology Inc’s recent filing unveils that its Director Smith Stan acquired Company’s shares for reported $24999.0 on Oct 01 ’25. In the deal valued at $1.30 per share,19,230 shares were bought. As a result of this transaction, Smith Stan now holds 1,324,289 shares worth roughly $2.37 million.
Then, Smith Stan bought 33,333 shares, generating $50,000 in total proceeds. Upon buying the shares at $1.50, the Director now owns 1,305,059 shares.
Before that, Guerrero Ramiro bought 20,000 shares. MAIA Biotechnology Inc shares valued at $30,000 were divested by the Director at a price of $1.50 per share. As a result of the transaction, Guerrero Ramiro now holds 588,218 shares, worth roughly $1.05 million.
Price Performance Review of MAIA
On Tuesday, MAIA Biotechnology Inc [AMEX:MAIA] saw its stock jump 3.47% to $1.79. Over the last five days, the stock has gained 16.23%. MAIA Biotechnology Inc shares have fallen nearly -31.15% since the year began. Nevertheless, the stocks have fallen -9.60% over the past one year. While a 52-week high of $3.48 was reached on 05/02/25, a 52-week low of $1.40 was recorded on 04/10/25.
Levels Of Support And Resistance For MAIA Stock
The 24-hour chart illustrates a support level at 1.7100, which if violated will result in even more drops to 1.6300. On the upside, there is a resistance level at 1.9200. A further resistance level may holdings at 2.0500.
How much short interest is there in MAIA Biotechnology Inc?
A steep rise in short interest was recorded in MAIA Biotechnology Inc stocks on 2025-09-15, growing by 0.22 million shares to a total of 0.85 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 0.63 million shares. There was a rise of 25.97%, which implies that there is a positive sentiment for the stock.
